Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Neurocrine Biosciences Inc (NASDAQ: NBIX) improved of late. NBIX’s current Value Trend Rating is B and the prior Rating was […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Ark Restaurants Corp. (NASDAQ: ARKR) fell significantly in recent days. ARKR’s current Value Trend Rating is F and the prior […]
Stock Rating Downgrade Of late the Value Trend Rating for Adobe Inc (NASDAQ: ADBE) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Adobe Inc (NASDAQ: ADBE) stock closed […]
Stock Rating Downgrade The Value Trend Rating for Manhattan Bridge Capital (NASDAQ: LOAN) weakened recently from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our […]
Catalyst Biosciences Inc (NASDAQ: CBIO) stock closed at $22.51 on 1/12/24 after a major decline of -14.6%. However, this decline was accompanied by unusually low trading volume at 58% of normal. The stock has been […]
Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Baidu Inc (NASDAQ: BIDU) improved during the last several trading days. BIDU’s current Value Trend Rating is B and the […]
Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Exelixis Inc (NASDAQ: EXEL) improved recently. EXEL’s current Value Trend Rating is B and the prior Rating was C. Details […]
Stock Rating Downgrade The Value Trend Rating for Manhattan Bridge Capital (NASDAQ: LOAN) weakened recently from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Ark Restaurants Corp. (NASDAQ: ARKR) fell significantly in recent days. ARKR’s current Value Trend Rating is F and the prior […]
On 1/12/24, T2 Biosystems Inc (NASDAQ: TTOO) stock suffered a major decline of -11.1%, closing at $4.16. However, this decline was accompanied by exceptionally low trading volume at 46% of normal. Relative to the market […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research